|
Risk Factors
Citations 541-550 of 1542 total displayed.
|
Past content
(since Jan 1999):
|
- Coronary Heart Disease
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
- Chris J. Packard, Ian Ford, Michele Robertson, James Shepherd, Gerard J. Blauw, Michael B. Murphy, Edward L.E.M. Bollen, Brendan M. Buckley, Stuart M. Cobbe, Allan Gaw, Michael Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, Ivan J. Perry, David J. Stott, Brian J. Sweeney, Cillian Twomey, Rudi G.J. Westendorp for the PROSPER Study Group
Circulation 2005;112:3058-3065; published online before print as doi:10.1161/CIRCULATIONAHA.104.526848
[Abstract]
[Full text]
- Epidemiology
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
- Peter W.F. Wilson, Ralph B. DAgostino, Helen Parise, Lisa Sullivan, and James B. Meigs
Circulation 2005;112:3066-3072; published online before print as doi:10.1161/CIRCULATIONAHA.105.539528
[Abstract]
[Full text]
- Epidemiology
Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study
- Ann Smith, Chris Patterson, John Yarnell, Ann Rumley, Yoav Ben-Shlomo, and Gordon Lowe
Circulation 2005;112:3080-3087, doi:10.1161/CIRCULATIONAHA.105.557132
[Abstract]
[Full text]
- Epidemiology
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
- Nadia A. Khan, Brenda R. Hemmelgarn, Marcello Tonelli, Christopher R. Thompson, and Adeera Levin
Circulation 2005;112:3088-3096, doi:10.1161/CIRCULATIONAHA.105.560128
[Abstract]
[Full text]
- Vascular Medicine
Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
- Manfredi Tesauro, Francesca Schinzari, Micaela Iantorno, Stefano Rizza, Domenico Melina, Davide Lauro, and Carmine Cardillo
Circulation 2005;112:2986-2992; published online before print as doi:10.1161/CIRCULATIONAHA.105.553883
[Abstract]
[Full text]
- Articles
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
- Peter W.F. Wilson, Ralph B. D’Agostino, Helen Parise, Lisa Sullivan, and James B. Meigs
Circulation published November 7, 2005, doi:10.1161/CIRCULATIONAHA.105.539528
[Abstract]
- Articles
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
- Chris J. Packard, Ian Ford, Michele Robertson, James Shepherd, Gerard J. Blauw, Michael B. Murphy, Edward L.E.M. Bollen, Brendan M. Buckley, Stuart M. Cobbe, Allan Gaw, Michael Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, Ivan J. Perry, David J. Stott, Brian J. Sweeney, Cillian Twomey, Rudi G.J. Westendorp for the PROSPER Study Group
Circulation published November 7, 2005, doi:10.1161/CIRCULATIONAHA.104.526848
[Abstract]
- Vascular Medicine
Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F2 -III: Evidence From Apolipoprotein E and LDL ReceptorDeficient Mice
- Myan Tang, Tillmann Cyrus, Yuemang Yao, Luigina Vocun, and Domenico Praticò
Circulation 2005;112:2867-2874, doi:10.1161/CIRCULATIONAHA105.562223
[Abstract]
[Full text]
- Articles
Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
- Manfredi Tesauro, Francesca Schinzari, Micaela Iantorno, Stefano Rizza, Domenico Melina, Davide Lauro, and Carmine Cardillo
Circulation published October 31, 2005, doi:10.1161/CIRCULATIONAHA.105.553883
[Abstract]
- Editorials
Oxidative Stress and the Vascular Wall: NADPH Oxidases Take Center Stage
- John F. Keaney, Jr
Circulation 2005;112:2585-2588, doi:10.1161/CIRCULATIONAHA.105.578146
[Full text]
|
|